Dr. Pardi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st Street SW
Rochester, MN 55905- Is this information wrong?
Summary
- Dr. Darrell Pardi is the Chair of the Division of Gastroenterology and Hepatology at Mayo Clinic in Rochester, MN. He received his medical degree from University of Rochester School of Medicine and Dentistry and has been in practice 25 years. He specializes in inflammatory bowel disease and C. difficile infection and is experienced in general gastroenterology, inflammatory bowel disease, ulcerative colitis, crohn's disease, and microscopic colitis.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 1995 - 1998
University of RochesterResidency, Internal Medicine, 1991 - 1995
University of Rochester School of Medicine and DentistryClass of 1991
Certifications & Licensure
FL State Medical License 2019 - 2026
AZ State Medical License 1995 - 2026
MN State Medical License 1997 - 2024
NY State Medical License 1993 - 1996- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease Start of enrollment: 2006 Jul 20
- SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) Start of enrollment: 2015 May 01
- Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis Start of enrollment: 2015 May 01
- Join now to see all
Publications & Presentations
PubMed
- Reply.June Tome, Sahil Khanna, Darrell S Pardi> ;Clinical Gastroenterology and Hepatology. 2024 Feb 15
- Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care.Nielsen, O., Pardi, D.> ;Drugs & Aging. 2024 Feb 1
- Durability and outcomes of fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with moderate to severe inflammatory bowel dis...Loftus, E., Khanna, S., Tariq, R., Pardi, D.> ;Intestinal Research. 2024 Jan 9
- Join now to see all
Journal Articles
- Colon Surgery Risk with Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients with Clostridium Difficile InfectionDipesh Solanky, Sahil Khanna, Darrell S Pardi, Inflammatory Bowel Diseases
Press Mentions
PureTech Founded Entity Vedanta Biosciences Publishes Phase 2 Results in the Journal of the American Medical Association and Presents at ECCMIDApril 17th, 2023- Artificial Intelligence Is Forging a New Future for GastroenterologyFebruary 3rd, 2023
- GI Physician Shortage ‘A Significant Concern’ Affecting Both Providers, PatientsDecember 28th, 2022
- Join now to see all
Professional Memberships
- Fellow
- Fellow
- Crohn's and Colitis Foundation of AmericaMember
Hospital Affiliations
Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
